Traditional and Digital health therapies, together and mixed up
Could digital medicine increase our life expectancy? Hopes (without hype) for a promising future.
Currently he leads two labs, one at the University of Tubingen, Germany and the other the largest Spanish private research center called Tecnalia. He is in human neurotechnology, brain-machine- or neural-interfaces, rehabilitation robotics, stroke rehabilitation, neural signal processing and transferring neuroscientific findings to market-/clinical-practice-ready neurotechnology. His subsequent PhD training at the International Max Planck Neuroscience Research School, University of Tubingen, Germany, for Behavioral and Neuroscience in clinical Brain-Machine-Interface technology allowed him to train extensively in adapting his technical skills to the clinical setting acquiring extensive experience in clinical trials. In parallel he continued working for Tecnalia further developing his transfer to market profile in neurotechnology. Following a Postdoc period, he became group leader (faculty) in the Institute of Medical Psychology and Behavioral Neurobiology at the University of Tübingen.
